CORZ drops as seller pressure weighs on short-term price action

Traders Union
All News
Stocks
Core Scientific slides 9.35% today

Highlights

Core Scientific booked $232.9 million in third quarter revenue for 2026, with non-cash gains driving net income to $1.2 billion.
Artificial intelligence colocation contributed 92% of quarterly revenue, while liquidity reached $1.7 billion after the Polaris acquisition and capital outlays.
Shares of Core Scientific trade below key moving averages with persistent bearish signals, expected to range from $8.78 to $12.33.

Revenue increases and AI hosting growth amid warrant-driven profits

Core Scientific reported $232.9 million in revenue for the third quarter of 2026, as released by Gurufocus, providing a clear update on the company's core business operations over the period. Colocation revenue grew sharply to approximately $215.4 million, indicating significant expansion in hosting activities and underlying client demand. Net income reached $1.2 billion, primarily due to a non-cash gain from warrants, which affects bottom-line results but does not represent an operational cash inflow, according to Gurufocus. The company’s artificial intelligence colocation business contributed 92% of total third-quarter revenue, as noted by Yahoo Finance, and Core Scientific held $1.7 billion in liquidity after substantial capital expenditures and the Polaris acquisition, Finance Biggo reported, though price action has remained under broader selling pressure.

Bearish momentum persists as oversold oscillators hint at rebound

CORZ is positioned below its MA-20 at $12.9, MA-50 at $13.56, and MA-200 at $19.57, suggesting ongoing downside across all measured timeframes. The Ichimoku Kijun level at $12.43 now acts as immediate resistance on the chart. Bearish momentum dominates, as indicated by both MACD and ADX flashing sell signals, while Bull/Bear Power and the Awesome Oscillator confirm intraday selling strength. Momentum oscillators provide some contrast: RSI remains neutral, but Stoch RSI at 6.64 and CCI at -237.28 are deeply oversold, flagging the emergence of short-term rebound potential even as dominant trend signals stay negative.

Sideways consolidation expected as downside risk outweighs breakout odds

In the short term, price action is likely to remain volatile within the $8.78 to $12.33 range. There is a relatively low probability (22%) of a sustained upward breakout, while downside continuation is favored (78%). A move above the $12.43 resistance would likely trigger renewed buying, while a breakdown below $8.78 would confirm further losses. The baseline scenario expects the stock to consolidate sideways within this volatility band.

Viktoras Karapetjanc, analyst at Traders Union, sees Core Scientific delivering strong fundamental growth, particularly in the AI colocation segment, backed by a robust liquidity position and aggressive reinvestment. However, he notes that market sentiment remains cautious, with price action decisively below all major moving averages and technicals indicating prevailing bearish momentum. The stock trades in a volatile consolidation zone, with downside risks outweighing immediate upside catalysts for now. Karapetjanc believes that while fundamentals are encouraging, investor conviction will likely improve only after a clear breakout above $12.43. "If Core Scientific can reclaim the $12.43 level and sustain recent operational gains, I expect renewed buying interest and upside momentum to return."

Earlier, analysts noted that broader selloffs in AI-linked infrastructure stocks—including Core Scientific—may not reflect deterioration in business fundamentals, as long-term power capacity remains a key value driver. The latest financial results showing robust colocation revenue growth and deep oversold signals add a new dimension, highlighting that while dominant trends are negative, short-term rebounds around the $8.78 to $12.43 range warrant attention as traders assess the next move.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.